151 related articles for article (PubMed ID: 16859519)
1. Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis.
Dejaco C; Klotz W; Larcher H; Duftner C; Schirmer M; Herold M
Arthritis Res Ther; 2006; 8(4):R119. PubMed ID: 16859519
[TBL] [Abstract][Full Text] [Related]
2. A study of the roles of some immunological biomarkers in the diagnosis of rheumatoid arthritis.
Khudhair HAA
J Med Life; 2023 Aug; 16(8):1194-1200. PubMed ID: 38024817
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis.
Vittecoq O; Incaurgarat B; Jouen-Beades F; Legoedec J; Letourneur O; Rolland D; Gervasi G; Ménard JF; Gayet A; Fardellone P; Daragon A; Jolivet M; le Loët X; Tron F
Clin Exp Immunol; 2004 Jan; 135(1):173-80. PubMed ID: 14678280
[TBL] [Abstract][Full Text] [Related]
4. Anti-cyclic citrullinated peptide (anti-CCP) and anti-mutated citrullinated vimentin (anti-MCV) relation with extra-articular manifestations in rheumatoid arthritis.
Gonzalez-Lopez L; Rocha-Muñoz AD; Ponce-Guarneros M; Flores-Chavez A; Salazar-Paramo M; Nava A; Cardona-Muñoz EG; Fajardo-Robledo NS; Zavaleta-Muñiz SA; Garcia-Cobian T; Gamez-Nava JI
J Immunol Res; 2014; 2014():536050. PubMed ID: 24804270
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic and prognostic value of IgG and IgA anti-citrullinated protein antibodies in patients with early rheumatoid arthritis.
Sieghart D; Konrad C; Swiniarski S; Haslacher H; Aletaha D; Steiner G
Front Immunol; 2022; 13():1096866. PubMed ID: 36685579
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of anti-mutated citrullinated vimentin antibodies in rheumatoid arthritis patients.
Hagras A; Mohasseb D; Taleb R; Bastawi R; Elnemr R
Hum Antibodies; 2024; 32(2):75-83. PubMed ID: 38669525
[TBL] [Abstract][Full Text] [Related]
7. Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test.
Di Matteo A; Mankia K; Garcia-Montoya L; Sharrack S; Duquenne L; Nam JL; Mahler M; Emery P
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38599655
[TBL] [Abstract][Full Text] [Related]
8. Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis.
Puszczewicz M; Iwaszkiewicz C
Arch Med Sci; 2011 Apr; 7(2):189-94. PubMed ID: 22291756
[TBL] [Abstract][Full Text] [Related]
9. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin.
Harre U; Georgess D; Bang H; Bozec A; Axmann R; Ossipova E; Jakobsson PJ; Baum W; Nimmerjahn F; Szarka E; Sarmay G; Krumbholz G; Neumann E; Toes R; Scherer HU; Catrina AI; Klareskog L; Jurdic P; Schett G
J Clin Invest; 2012 May; 122(5):1791-802. PubMed ID: 22505457
[TBL] [Abstract][Full Text] [Related]
10. Importance of 14-3-3eta, anti-CarP, and anti-Sa in the diagnosis of seronegative rheumatoid arthritis.
Salman E; Çetiner S; Boral B; Kibar F; Erken E; Ersözlü ED; Badak SÖ; Bilici Salman R; Sertdemir Y; Çetin Duran A; Yaman A
Turk J Med Sci; 2019 Oct; 49(5):1498-1502. PubMed ID: 31651120
[TBL] [Abstract][Full Text] [Related]
11. Anti-mutated citrullinated vimentin antibodies are increased in IPF patients.
Le Guen P; Tardivon C; Laouénan C; Debray MP; Nicaise Roland P; Taillé C; Borie R; Ottaviani S; Guenther A; Dieudé P; Crestani B
Respir Med Res; 2024 Jun; 85():101081. PubMed ID: 38232658
[TBL] [Abstract][Full Text] [Related]
12. Improved serological detection of rheumatoid arthritis: a highly antigenic mimotope of carbonic anhydrase III selected in a murine model by phage display.
Araujo GR; Vaz ER; Fujimura PT; Fonseca JE; de Lima LM; Canhão H; Venturini G; Cardozo KH; Carvalho VM; Napimoga MH; Goulart LR; Gonçalves J; Ueira-Vieira C
Arthritis Res Ther; 2015 Jun; 17(1):168. PubMed ID: 26099944
[TBL] [Abstract][Full Text] [Related]
13. Anti-CCP biosensors in rheumatoid arthritis.
Karami P; Gholamin D; Fathi F; Afsar T; Johari-Ahar M
Clin Chim Acta; 2024 Jun; 561():119767. PubMed ID: 38857671
[TBL] [Abstract][Full Text] [Related]
14. Anti-citrullinated protein antibodies dominate the association of long-term outcomes and anti-modified protein antibodies in rheumatoid arthritis.
van Wesemael TJ; Verstappen M; Knevel R; van der Helm-van Mil AHM; Toes REM; van der Woude D
Lancet Rheumatol; 2022 May; 4(5):e316-e317. PubMed ID: 38294031
[No Abstract] [Full Text] [Related]
15. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.
Bang H; Egerer K; Gauliard A; Lüthke K; Rudolph PE; Fredenhagen G; Berg W; Feist E; Burmester GR
Arthritis Rheum; 2007 Aug; 56(8):2503-11. PubMed ID: 17665451
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis: compared with anti-CCP and rheumatoid factor, could anti-MCV be the next biomarker in the rheumatoid arthritis classification criteria?
Zhu JN; Nie LY; Lu XY; Wu HX
Clin Chem Lab Med; 2019 Oct; 57(11):1668-1679. PubMed ID: 31141478
[TBL] [Abstract][Full Text] [Related]
17. Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis.
Mutlu N; Bicakcigil M; Tasan DA; Kaya A; Yavuz S; Ozden AI
J Rheumatol; 2009 Mar; 36(3):491-500. PubMed ID: 19228660
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
[TBL] [Abstract][Full Text] [Related]
19. Rheumatoid arthritis sera antibodies to citrullinated collagen type II bind to joint cartilage.
Li Q; Li Y; Liang B; Xu R; Xu B; Lönnblom E; Feng H; Bai J; Stawikowska R; Ge C; Lu A; Fields GB; Xiao L; Holmdahl R
Arthritis Res Ther; 2022 Nov; 24(1):257. PubMed ID: 36419093
[TBL] [Abstract][Full Text] [Related]
20. Impact of Posttranslational Modification in Pathogenesis of Rheumatoid Arthritis: Focusing on Citrullination, Carbamylation, and Acetylation.
Kwon EJ; Ju JH
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
